Pharma-Bio Serv (PBSV) News Today $0.60 -0.09 (-13.03%) As of 02:41 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartDividendEarningsSEC FilingsShort InterestBuy This Stock PBSV Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Pharma-Bio Serv (OTCMKTS:PBSV) vs. Bureau Veritas Registre International De Classification (OTCMKTS:BVRDF) Head to Head ComparisonSeptember 29, 2025 | americanbankingnews.comHead-To-Head Survey: Pharma-Bio Serv (OTCMKTS:PBSV) & Bureau Veritas Registre International De Classification (OTCMKTS:BVRDF)September 28, 2025 | americanbankingnews.comPBSV Set to Implement Growth InitiativesSeptember 16, 2025 | msn.comPBSV Pharma-Bio Serv, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comOTC:PBSV Financials | Pharma-Bio Serv Inc - Investing.comJune 26, 2025 | investing.comPBSV Decisions Paying OffJune 19, 2025 | msn.comPBSV Returns to GrowthMarch 18, 2025 | msn.comPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Full Year ResultsJanuary 31, 2025 | finanznachrichten.dePBSV Released Earnings and Declares DividendJanuary 30, 2025 | msn.comPharma-Bio Serv declares special dividend for shareholdersJanuary 30, 2025 | msn.comScotiabank Initiates Coverage of BridgeBio Pharma (BBIO) with Sector Outperform RecommendationOctober 17, 2024 | msn.comBristol Myers, 2seventy bio halt enrollment in Abecma late-stage trialSeptember 25, 2024 | msn.comPBSV Makes Progress on ImprovementsSeptember 17, 2024 | msn.comPharma-Bio Serv Inc PBSVAugust 8, 2024 | morningstar.comMSamsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier PartnerAugust 6, 2024 | msn.comPharma-Bio Serv Inc.May 18, 2024 | wsj.comKörber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive RankingMay 14, 2024 | msn.comBBIO Stock Earnings: BridgeBio Pharma Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | markets.businessinsider.comDeep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)April 25, 2024 | markets.businessinsider.comEQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché LaboratóriosApril 25, 2024 | markets.businessinsider.comBiomarin Pharmaceutical earnings preview: what Wall Street is expectingApril 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market ExpectationsApril 16, 2024 | markets.businessinsider.comSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment ProgramApril 9, 2024 | tmcnet.comLooking Into Biomarin Pharmaceutical's Recent Short InterestApril 3, 2024 | benzinga.comPBSV Releases Quarterly ResultsMarch 19, 2024 | finance.yahoo.comPharma-Bio Serv reports Q1 resultsMarch 19, 2024 | seekingalpha.comBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial OutlookMarch 4, 2024 | markets.businessinsider.comMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market UncertaintiesMarch 4, 2024 | markets.businessinsider.comBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- UpdateFebruary 26, 2024 | marketwatch.comStrong Voxzogo Performance Underpins Buy Rating for BioMarin PharmaceuticalFebruary 23, 2024 | markets.businessinsider.comPBSV Expands Margins and MarketsJanuary 30, 2024 | finance.yahoo.comJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger DealJanuary 28, 2024 | msn.comOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth DriversJanuary 9, 2024 | markets.businessinsider.comBridgeBio Pharma's Robust Pipeline Could Benefit From A PartnerJanuary 8, 2024 | seekingalpha.comPBSV Reward Shareholders with High YieldJanuary 3, 2024 | finance.yahoo.comPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special DividendDecember 21, 2023 | finanznachrichten.deAbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?December 8, 2023 | msn.comBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In GermanyNovember 28, 2023 | markets.businessinsider.comPromising Future for BridgeBio Pharma: Lebovitz’s Buy Rating Backed by Potential Blockbusters and Pipeline AssetsNovember 7, 2023 | markets.businessinsider.comBridgeBio Pharma Receives Buy Rating Amid Promising Drug Pipeline Developments and Strong Financial PositionNovember 6, 2023 | markets.businessinsider.comPBSV Boosts Margins and Expands MarketsSeptember 15, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023September 14, 2023 | finance.yahoo.comAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)August 31, 2023 | markets.businessinsider.comPharma-Bio Serv IncJuly 28, 2023 | thestreet.comBridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 CatalystsJuly 17, 2023 | msn.comBridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease StudyJuly 14, 2023 | marketwatch.comStocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft EnterprisesJuly 14, 2023 | marketwatch.comPearl Bio Secures Breakthrough IP for Multi-Functionalized BiologicsJune 20, 2023 | technews.tmcnet.comPBSV: A Consistent Performer with Impressive DividendJune 15, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023June 14, 2023 | finance.yahoo.com Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBSV Media Mentions By Week PBSV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBSV News Sentiment▼0.000.66▲Average Business Services News Sentiment PBSV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBSV Articles This Week▼00▲PBSV Articles Average Week Get the Latest News and Ratings for PBSV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Pharma-Bio Serv and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ANTE News Today NOTV News Today INUV News Today BGSF News Today ONMD News Today BTCM News Today JANL News Today SCOR News Today FTFT News Today LUNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PBSV) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma-Bio Serv With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
